Stock Yards Bank & Trust Co. Invests $249,000 in Teleflex Incorporated (NYSE:TFX)

Stock Yards Bank & Trust Co. bought a new stake in shares of Teleflex Incorporated (NYSE:TFX) in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm bought 1,000 shares of the medical technology company’s stock, valued at approximately $249,000.

Several other institutional investors also recently bought and sold shares of TFX. GHP Investment Advisors Inc. grew its stake in Teleflex by 18.7% during the third quarter. GHP Investment Advisors Inc. now owns 7,919 shares of the medical technology company’s stock valued at $1,501,000 after acquiring an additional 1,246 shares in the last quarter. Exchange Traded Concepts LLC grew its stake in shares of Teleflex by 157.5% in the 3rd quarter. Exchange Traded Concepts LLC now owns 273 shares of the medical technology company’s stock worth $54,000 after buying an additional 167 shares in the last quarter. Boston Trust Walden Corp grew its stake in shares of Teleflex by 0.4% in the 3rd quarter. Boston Trust Walden Corp now owns 193,788 shares of the medical technology company’s stock worth $38,062,000 after buying an additional 749 shares in the last quarter. Next Capital Management LLC grew its stake in shares of Teleflex by 4.4% in the 3rd quarter. Next Capital Management LLC now owns 9,723 shares of the medical technology company’s stock worth $1,910,000 after buying an additional 409 shares in the last quarter. Finally, Czech National Bank grew its stake in shares of Teleflex by 47.7% in the 3rd quarter. Czech National Bank now owns 8,213 shares of the medical technology company’s stock worth $1,613,000 after buying an additional 2,653 shares in the last quarter. 95.62% of the stock is owned by hedge funds and other institutional investors.

Teleflex Price Performance

Teleflex stock opened at $211.17 on Thursday. Teleflex Incorporated has a 12-month low of $177.63 and a 12-month high of $276.43. The firm has a 50-day moving average price of $223.09 and a 200-day moving average price of $225.66. The firm has a market capitalization of $9.95 billion, a PE ratio of 28.04, a price-to-earnings-growth ratio of 2.02 and a beta of 1.11. The company has a current ratio of 2.32, a quick ratio of 1.29 and a debt-to-equity ratio of 0.39.

Teleflex (NYSE:TFX) last announced its quarterly earnings data on Thursday, February 22nd. The medical technology company reported $3.38 earnings per share for the quarter, beating analysts’ consensus estimates of $3.26 by $0.12. The company had revenue of $773.90 million during the quarter, compared to analyst estimates of $769.01 million. Teleflex had a net margin of 11.98% and a return on equity of 14.98%. The firm’s revenue for the quarter was up 2.1% on a year-over-year basis. During the same quarter last year, the business posted $3.52 EPS. As a group, equities research analysts forecast that Teleflex Incorporated will post 13.73 EPS for the current year.

Teleflex Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, March 15th. Shareholders of record on Friday, March 1st were given a dividend of $0.34 per share. This represents a $1.36 dividend on an annualized basis and a yield of 0.64%. The ex-dividend date was Thursday, February 29th. Teleflex’s dividend payout ratio (DPR) is 18.06%.

Insider Buying and Selling at Teleflex

In other Teleflex news, VP Cameron P. Hicks sold 7,401 shares of the firm’s stock in a transaction dated Tuesday, March 5th. The shares were sold at an average price of $225.00, for a total transaction of $1,665,225.00. Following the transaction, the vice president now owns 10,050 shares of the company’s stock, valued at approximately $2,261,250. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 1.43% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities analysts have commented on TFX shares. JMP Securities reissued a “market outperform” rating and issued a $285.00 price objective on shares of Teleflex in a research note on Friday, February 23rd. StockNews.com cut shares of Teleflex from a “buy” rating to a “hold” rating in a research note on Friday, February 23rd. Truist Financial dropped their price objective on shares of Teleflex from $270.00 to $265.00 and set a “hold” rating for the company in a research note on Friday, February 23rd. Finally, Royal Bank of Canada lowered their target price on shares of Teleflex from $272.00 to $265.00 and set an “outperform” rating for the company in a report on Friday, February 23rd. Five analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $267.50.

Teleflex Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.